A single intramuscular injection of a self-amplifying RNA therapy produced weeks of heart-protective protein in rat models of myocardial infarction, according to a study published in Science on March ...

Japan approves world-first iPS cell therapies for heart failure, Parkinsons Conditional approvals speed Japans first iPS ...

Study shows that cardiac spheroids, derived from human induced pluripotent stem cells, can be easily transported and injected into damaged areas of the heart to promote its regeneration and recovery ...

A groundbreaking study shatters the myth of permanent cardiac damage, revealing that the heart can naturally trigger cell ...

Tenaya’s Highly Selective HDAC6 Inhibitor TN-301 Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting ...

Anatomically, cardiac rupture occurs at the intersection between injured and healthy cardiac tissue. This region is referred to as the borderzone. The conventional view is that increased mechanical ...

Japan's health ministry said Friday it has conditionally approved production and sales of two novel regenerative therapies capitalizing on induced pluripotent stem cells. The world's first permission ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...

A research team from Xi'an Jiaotong University has developed a new method for bioprinting skeletal muscle tissue.

Japan's health ministry said Friday it has conditionally approved the production and sales of two regenerative medical products using induced pluripotent stem cells. The approval was given to ...